Lynn E Taylor
Affiliation: Rhode Island Hospital
- Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of riskL E Taylor
Department of Medicine, Division of Infectious Disease, Brown University, Providence, Rhode Island 02906, USA
AIDS Patient Care STDS 25:571-7. 2011..Tracking quarterly ALT for elevation to systematically prompt HCV RNA testing before seroconversion is a promising approach to screen for acute HCV in a real-world HIV clinical setting...
- Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?Lynn E Taylor
The Warren Alpert Medical School of Brown University Miriam Hospital, 164 Summit Avenue, Center for AIDS Research Building Room 156, Providence, RI 02906, USA
J Addict Med 6:179-85. 2012..Buprenorphine facilitates hepatitis C virus (HCV) treatment in opioid-dependent patients with HCV monoinfection. Less is known about buprenorphine's role in HIV/HCV coinfection...
- HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigmsLynn E Taylor
Department of Medicine, Brown University, Providence, RI 02906, USA
Clin Infect Dis 55:S33-42. 2012..HCV drug trials in individuals coinfected with HIV should be expedited. HIV/HCV coinfection remains a growing and evolving epidemic; new developments in therapeutics and improved care models offer promise...
- Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapyLynn E Taylor
The Warren Alpert Medical School of Brown University, USA
Drug Alcohol Depend 116:233-7. 2011..HCV therapy for HCV-monoinfected methadone maintenance (MM) recipients is safe and effective. We evaluated treatment efficacy and adherence to pegylated interferon (pegIFN) among HIV/HCV coinfected MM recipients...
- Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trialsLynn E Taylor
Department of Medicine, Brown University, Providence, Rhode Island, USA
Clin Infect Dis 52:812-8. 2011..Whether this is occurring across the United States is unknown...
- Delivering care to injection drug users coinfected with HIV and hepatitis C virusLynn E Taylor
Department of Medicine, Division of Infectious Disease, Brown Medical School, Providence, Rhode Island, USA
Clin Infect Dis 40:S355-61. 2005..Presented here is a work in progress, rather than a finished research project or definitive model of care...
- Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependenceLynn E Taylor
The Miriam Hospital, Providence, RI, USA
Clin Infect Dis 36:1501-2; author reply 1502-3. 2003
- A syringe prescription program to prevent infectious disease and improve health of injection drug usersJosiah D Rich
School of Medicine at Brown University, The Miriam Hospital, 164 Summit Avenue, Providence, RI 02906, USA
J Urban Health 81:122-34. 2004..The syringe prescription program in Providence represents a promising and innovative approach to disease prevention and treatment for IDUs...
- Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis CKara W Chew
Department of Medicine, University of California at San Francisco, San Francisco, CA 94115, USA
J Clin Gastroenterol 43:686-91. 2009..To report our experience with pegylated interferon and ribavirin treatment of hepatitis C virus (HCV) RNA-positive inmates at the Rhode Island Department of Corrections...
- Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case reportLynn E Taylor
Department of Medicine, Division of Infectious Disease, Brown Medical School, Providence, RI, USA
AIDS Read 15:629-31, 634-6, 638. 2005..This case suggests that HIV-HCV-coinfected persons with the common comorbidities of polysubstance dependence and psychiatric illness may effectively and safely undergo pharmacotherapy for hepatitis C with appropriate support...
- Prescribing syringes to injection drug users with HIV: an important clinical and public health toolMichelle A Stozek
Brown University, Providence, Rhode Island, USA
J Assoc Nurses AIDS Care 15:59-63. 2004
- Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infectionTimothy P Flanigan
Department of Medicine, The Miriam Hospital, Brown University School of Medicine, Providence, Rhode Island 02906, USA
Clin Infect Dis 40:S346-8. 2005..DOT can both optimize adherence and provide a way to offer psychosocial support and linkages to social, addiction, psychiatric, and other services, to help address many of the challenges faced by persons with substance abuse disorders...
- Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virusAndrew R Lai
Brown Medical School, Providence, Rhode Island, USA
AIDS Patient Care STDS 20:678-92. 2006..We review the current data on the use of antiretrovirals in HIV/HCV-coinfected patients and offer evidence-based recommendations on optimal selection and dosing of antiretroviral agents for this population...
- Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapyLynn E Taylor
Department of Medicine, Brown University, Providence, Rhode Island, USA
Clin Infect Dis 57:S118-24. 2013..The ultimate goal must be the elimination of HCV from all coinfected PWID. ..
- Would you consider prescribing syringes to injection drug users? Addiction Medicine Conference SurveyLynn E Taylor
The Miriam Hospital andBrown University, Providence, RI 02906, USA
J Addict Dis 22:67-78. 2003..The majority of physicians surveyed expressed interest in prescribing syringes. Psychiatrists may be less willing to do so...
- The Spectrum of Undiagnosed Hepatitis C Virus Infection in a US HIV ClinicLynn E Taylor
1 Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island
AIDS Patient Care STDS 28:4-9. 2014..Adding annual rescreening to the Ryan White Program would facilitate earlier identification of undiagnosed HCV and create an instant widespread surveillance system, providing HCV incidence data. ..
- Pharmacist support for selling syringes without a prescription to injection drug users in Rhode IslandJosiah D Rich
Brown Medical School, and The Miriam Hospital, Providence, Rhode Island 02906, USA
J Am Pharm Assoc (Wash) 42:S58-61. 2002..To examine pharmacists' attitudes and obstacles to syringe sales to IDUs without prescriptions in Rhode Island, around the time that such sales became legal in the state...
- Twinrix vaccination schedules among injecting drug usersNancy Brim
Brown Medical School, Providence, Rhode Island, USA, 2The Miriam Hospital, 164 Summit Ave, Providence, RI 02906, USA
Expert Opin Biol Ther 7:379-89. 2007..The authors conclude that there is insufficient evidence regarding whether the accelerated Twinrix HAV/HBV vaccination schedule would yield a greater number of IDUs protected against both HAV and HBV...
- Ten things you may not know about hepatitis C infectionEdward Feller
Brown Medical School, Division of Gastroenterology, Miriam Hospital Division of Gastroenterology, 164 Summit Ave, Providence, RI 02906, USA
Med Health R I 85:180-1. 2002
- Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patientsBarbara H McGovern
HIV HCV Co infection Clinic, Lemuel Shattuck Hospital, Jamaica Plain, Jamaica Plain, MA 02494, USA
Clin Infect Dis 43:365-72. 2006....
- Peginterferon plus ribavirin for hepatitis C in HIV-infected patientsLynn E Taylor
N Engl J Med 351:2340-2; author reply 2340-2. 2004
- Treatment of chronic hepatitis C in a state correctional facilityScott A Allen
Rhode Island Department of Corrections, 39 Howard Avenue, Cranston, RI 02920, USA
Ann Intern Med 138:187-90. 2003..Currently, there are few reports of treatment outcomes of this common infection in this setting...
- Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individualsLynn E Taylor
AIDS 16:1700-1. 2002
- Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter studyNorbert Brau
Bronx Veterans Affairs VA Medical Center, Infectious Disease Section 111F, 130 West Kingsbridge Road, Bronx, NY 10468, USA
J Hepatol 47:527-37. 2007..HIV-infected patients now live longer and often have complications of liver disease, especially with hepatitis B or C virus coinfection. Limited data are available on those with hepatocellular carcinoma (HCC)...
- Screening for hepatitis C virus infection in adultsJosiah D Rich
Ann Intern Med 141:575-6; author reply 576. 2004
- Intrahepatic cytokine expression is downregulated during HCV/HIV co-infectionJason T Blackard
Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
J Med Virol 78:202-7. 2006..These data suggest that a defect in cytokine activation may occur in HCV/HIV co-infected persons that limits efficient clearance of HCV from the liver...